Cellular & Molecular Biology Letters, 2023 · DOI: https://doi.org/10.1186/s11658-023-00417-0 · Published: January 5, 2023
This study investigates how photobiomodulation (PBM) can help repair spinal cord injuries (SCI) by reducing inflammation and nerve damage. It focuses on bone-marrow-derived macrophages (BMDMs), which are recruited to the injured area after SCI and can cause inflammation and neuronal apoptosis. The research explores the role of a specific molecular pathway involving lncRNA TUG1, miR-1192, and TLR3 in the process. PBM treatment was found to reduce the expression of TUG1, TLR3, and inflammatory cytokines, promoting nerve survival and motor function recovery in mice with SCI. The study concludes that the lncRNA TUG1/miR-1192/TLR3 axis is an important pathway for PBM to inhibit M1 macrophage polarization and inflammation. This provides a basis for using PBM in clinical applications for patients with SCI.
The findings provide theoretical support for the clinical application of PBM in treating spinal cord injuries.
lncRNA TUG1 is identified as a potential therapeutic target for managing inflammation and promoting nerve regeneration in SCI.
Modulating the TUG1-miR-1192-TLR3 axis may offer a novel approach to control macrophage polarization and reduce secondary inflammatory responses after SCI.